查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1675351

2025 年至 2033 年按产品类型、人口统计（成年人口、儿童人口）、适应症、最终用户（诊断/诊所、重症监护病房、家庭医疗保健）和地区分類的下一代糖尿病治疗和药物传输市场

Next Generation Diabetes Therapy and Drug Delivery Market by Product Type, Demographic (Adult Population, Child Population ), Indication, End User (Diagnostic/Clinics, Intensive Care Units, Home Healthcare), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

2024IMARC Group全球下一代糖尿病治疗和药物输送市场规模将达到 112 亿美元。糖尿病（尤其是第 2 型糖尿病）盛行率的上升、技术的不断进步以及老年人口的不断增长是推动市场发展的一些关键因素。

下一代糖尿病治疗和药物传递程序专注于以微创方式将胰岛素引入患者体内，以减少频繁使用针头而引起皮肤刺激的风险。这种患者友善方法旨在利用穿戴式感测器、微针和可吸入胰岛素等创新技术有效管理疾病，同时降低医疗成本。也采用持续血糖监测系统 (CGMS)、人工胰臟和胰岛素贴片等先进疗法来改善血糖水平管理，从而最大限度地降低糖尿病相关併发症的风险。此外，该程序还可以轻鬆计算剂量，即时检查血糖水平，并无痛地将胰岛素输送到体内，进而有助于维持给药时间。这种治疗和药物传递实践的优点包括改善患者的治疗效果、提高治疗效率、最大限度地减轻患者的糖尿病管理负担，从而製定更有针对性的治疗计划。

下一代糖尿病治疗和药物传输市场趋势：

全球市场的主要驱动因素是糖尿病，尤其是第 2 型糖尿病在人群中的盛行率不断上升。这可以归因于不健康饮食、久坐的生活方式和体力活动减少的增加。与此相符的是，根据个人需求、生活方式和治疗目标对个人化和以患者为中心的护理的需求不断增加，从而导致产品使用率的提高。此外，智慧胰岛素笔、闭环系统和副作用更少的植入式设备等不断的技术进步正在为市场提供动力。除此之外，个人对微创和无痛治疗方案的日益重视也是推动市场成长的重要因素。医疗保健支出的不断增加以及对基于价值的医疗保健解决方案的更加关注进一步推动了市场的发展。然而，发展中地区不断增长的成本限制、缺乏认知以及产品多样性较低正成为限制市场成长的主要因素。相反，政府在预防保健和早期干预方面实施的优惠措施和报销政策为市场创造了积极的前景。除此之外，老年人口的不断增长使得他们更容易患上慢性病，这也对市场产生了积极影响。其他影响市场发展的因素包括快速的城市化、对传统糖尿病治疗相关併发症的认识不断提高、远距医疗和数位健康解决方案的采用不断增加、可支配收入水平不断上升以及主要参与者开展的广泛研发 (R&D) 活动。

本报告回答的关键问题：

  • 全球下一代糖尿病治疗和药物传输市场目前表现如何，未来几年将如何表现？
  • 全球下一代糖尿病治疗和药物传输市场有哪些驱动因素、限制因素和机会？
  • 每个驱动因素、限制因素和机会对全球下一代糖尿病治疗和药物传输市场有何影响？
  • 主要的区域市场有哪些？
  • 哪些国家代表了全球最具吸引力的下一代糖尿病治疗和药物传输市场？
  • 根据产品类型，市场如何划分？
  • 全球下一代糖尿病治疗和药物传输市场中最具吸引力的产品类型是哪一种？
  • 根据人口统计数据，市场如何划分？
  • 全球下一代糖尿病治疗和药物传输市场中最具吸引力的人口统计数据是哪一个？
  • 根据指示，市场的分拆情况如何？
  • 全球下一代糖尿病治疗和药物传输市场中最具吸引力的适应症是什么？
  • 根据最终用户，市场分布如何？
  • 全球下一代糖尿病治疗和药物传输市场中最具吸引力的最终用户是哪一个？
  • 全球下一代糖尿病治疗和药物传输市场的竞争结构是怎么样的？
  • 全球下一代糖尿病治疗和药物输送市场的关键参与者/公司是谁？

目录

第 1 章：前言

第 2 章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球下一代糖尿病治疗与药物传递市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第六章：市场区隔：依产品类型

  • 吸入式胰岛素
  • 口服胰岛素
  • 胰岛素贴片
  • CGM 系统
  • 人工胰臟

第七章：市场区隔：依人口结构

  • 成年人口（14 岁以上）
  • 儿童人口（14岁）

第 8 章：市场区隔：按适应症

  • 1 型糖尿病
  • 2 型糖尿病

第 9 章：市场区隔：按最终用户

  • 诊断/诊所
  • 重症加护病房（ICU）
  • 家庭医疗保健

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第 11 章：驱动因素、限制因素与机会

  • 概述
  • 驱动程式
  • 限制
  • 机会

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Dexcom Inc.
    • Eli Lilly and Company
    • Enteris BioPharma Inc. (Swk Holdings Corporation)
    • GlySens Incorporated
    • MannKind Corporation
    • Medtronic plc
    • Sanofi
    • Senseonics
Product Code: SR112025A7519

The global next generation diabetes therapy and drug delivery market size reached USD 11.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 37.0 Billion by 2033, exhibiting a growth rate (CAGR) of 13.52% during 2025-2033. The rising prevalence of diabetes, particularly type-2 diabetes, continual technological advancements, and the growing geriatric population represent some of the key factors driving the market.

Next generation diabetes therapy and drug delivery procedure focuses on the introduction of insulin into the patient's body in a minimally invasive manner to reduce the risk of skin irritation from frequent needle usage. This patient-friendly approach aims to effectively manage the disease while reducing healthcare costs by utilizing innovative technologies including wearable sensors, micro-needles, and inhalable insulin. Advanced therapies, such as continuous glucose monitoring systems (CGMS), artificial pancreas, and insulin patches, are also employed to improve blood sugar level management that minimize the risks of diabetic-related complications. In addition, the procedure facilitates easy calculation of the dose volume, checking the blood glucose levels in real-time, and delivers insulin into the body painlessly, which, in turn, helps to maintain the dosage time. Some of the advantages of this therapy and drug delivery practice includes improved patient outcomes, enhanced treatment efficiency, and minimized burden of diabetes management for patients, leading to more targeted treatment plans.

Next Generation Diabetes Therapy and Drug Delivery Market Trends:

The global market is primarily driven by the rising prevalence of diabetes, particularly type-2 diabetes, among the masses. This can be attributed to the increasing consumption of unhealthy diets, sedentary lifestyles and reduced physical activity. In line with this, the augmenting demand for personalized and patient-centric care according to individual needs, lifestyle, and treatment goals is resulting in a higher product uptake. Moreover, continual technological advancements, such as the development of smart insulin pens, closed-loop systems, and implantable devices with fewer side effects, is providing an impetus to the market. In addition to this, the increasing emphasis on minimally invasive and pain-free treatment options among individuals is also acting as a significant growth-inducing factor for the market. The market is further driven by the increasing healthcare expenditure, along with an enhanced focus on value-based medical care solutions. However, the growing cost restrains, lack of awareness and less variability in products in the developing regions are acting as major growth-restraining factors for the market. Conversely, the implementation of favorable government initiatives and reimbursement policies regarding preventive healthcare and early intervention is creating a positive outlook for the market. Apart from this, the growing geriatric population that is more susceptible to developing chronic diseases is impacting the market favorably. Some of the other factors contributing to the market include rapid urbanization, increasing awareness regarding the associated complications of traditional diabetes treatment, rising adoption of telehealth and digital health solutions, inflating disposable income levels and extensive research and development (R&D) activities conducted by key players.

Key Market Segmentation:

Product Type Insights:

  • Inhalable Insulin
  • Oral Insulin
  • Insulin Patches
  • CGM Systems
  • Artificial Pancreas

Demographic Insights:

  • Adult Population (>14 Years)
  • Child Population (14 Years)

Indication Insights:

  • Type 1 diabetes
  • Type 2 diabetes

End User Insights:

  • Diagnostic/Clinics
  • Intensive Care Units (ICUs)
  • Home Healthcare

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for next generation diabetes therapy and drug delivery. Some of the factors driving the North America next generation diabetes therapy and drug delivery market included the aging population, continual technological advancements, high healthcare expenditure, etc.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global next generation diabetes therapy and drug delivery market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, Dexcom Inc., Eli Lilly and Company, Enteris BioPharma Inc. (Swk Holdings Corporation), GlySens Incorporated, MannKind Corporation, Medtronic plc, Sanofi, Senseonics, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global next generation diabetes therapy and drug delivery market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global next generation diabetes therapy and drug delivery market?
  • What is the impact of each driver, restraint, and opportunity on the global next generation diabetes therapy and drug delivery market?
  • What are the key regional markets?
  • Which countries represent the most attractive global next generation diabetes therapy and drug delivery market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the global next generation diabetes therapy and drug delivery market?
  • What is the breakup of the market based on the demographic?
  • Which is the most attractive demographic in the global next generation diabetes therapy and drug delivery market?
  • What is the breakup of the market based on the indication?
  • Which is the most attractive indication in the global next generation diabetes therapy and drug delivery market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the global next generation diabetes therapy and drug delivery market?
  • What is the competitive structure of the global next generation diabetes therapy and drug delivery market?
  • Who are the key players/companies in the global next generation diabetes therapy and drug delivery market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Next Generation Diabetes Therapy and Drug Delivery Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Inhalable Insulin
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Oral Insulin
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Insulin Patches
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 CGM Systems
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Artificial Pancreas
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Demographic

  • 7.1 Adult Population (>14 Years)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Child Population (14 Years)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Indication

  • 8.1 Type 1 Diabetes
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Type 2 Diabetes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Diagnostic/Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Intensive Care Units (ICUs)
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Home Healthcare
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Dexcom Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Eli Lilly and Company
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Enteris BioPharma Inc. (Swk Holdings Corporation)
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 GlySens Incorporated
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 MannKind Corporation
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Medtronic plc
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Sanofi
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Senseonics
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Major Drivers and Challenges
  • Figure 2: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Product Type (in %), 2024
  • Figure 5: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Demographic (in %), 2024
  • Figure 6: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Indication (in %), 2024
  • Figure 7: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Next Generation Diabetes Therapy and Drug Delivery (Inhalable Insulin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Next Generation Diabetes Therapy and Drug Delivery (Inhalable Insulin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Next Generation Diabetes Therapy and Drug Delivery (Oral Insulin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Next Generation Diabetes Therapy and Drug Delivery (Oral Insulin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Next Generation Diabetes Therapy and Drug Delivery (Insulin Patches) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Next Generation Diabetes Therapy and Drug Delivery (Insulin Patches) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Next Generation Diabetes Therapy and Drug Delivery (CGM Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Next Generation Diabetes Therapy and Drug Delivery (CGM Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Next Generation Diabetes Therapy and Drug Delivery (Artificial Pancreas) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Next Generation Diabetes Therapy and Drug Delivery (Artificial Pancreas) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Next Generation Diabetes Therapy and Drug Delivery (Adult Population (>14 Years)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Next Generation Diabetes Therapy and Drug Delivery (Adult Population (>14 Years)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Next Generation Diabetes Therapy and Drug Delivery (Child Population (14 Years)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Next Generation Diabetes Therapy and Drug Delivery (Child Population (14 Years)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Next Generation Diabetes Therapy and Drug Delivery (Type 1 Diabetes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Next Generation Diabetes Therapy and Drug Delivery (Type 1 Diabetes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Next Generation Diabetes Therapy and Drug Delivery (Type 2 Diabetes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Next Generation Diabetes Therapy and Drug Delivery (Type 2 Diabetes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Next Generation Diabetes Therapy and Drug Delivery (Diagnostic/Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Next Generation Diabetes Therapy and Drug Delivery (Diagnostic/Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Next Generation Diabetes Therapy and Drug Delivery (Intensive Care Units (ICUs)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Next Generation Diabetes Therapy and Drug Delivery (Intensive Care Units (ICUs)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Next Generation Diabetes Therapy and Drug Delivery (Home Healthcare) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Next Generation Diabetes Therapy and Drug Delivery (Home Healthcare) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: North America: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: North America: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: United States: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: United States: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Canada: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Canada: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Asia-Pacific: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Asia-Pacific: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: China: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: China: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Japan: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Japan: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: India: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: India: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: South Korea: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: South Korea: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Australia: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Australia: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Indonesia: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Indonesia: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Others: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Others: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Europe: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Europe: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Germany: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Germany: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: France: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: France: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: United Kingdom: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: United Kingdom: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Italy: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Italy: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Spain: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Spain: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Russia: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Russia: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Others: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Others: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Latin America: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Latin America: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Brazil: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Brazil: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Mexico: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Mexico: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Others: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Others: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Middle East and Africa: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Middle East and Africa: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Country (in %), 2024
  • Figure 81: Middle East and Africa: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Global: Next Generation Diabetes Therapy and Drug Delivery Industry: Drivers, Restraints, and Opportunities
  • Figure 83: Global: Next Generation Diabetes Therapy and Drug Delivery Industry: Value Chain Analysis
  • Figure 84: Global: Next Generation Diabetes Therapy and Drug Delivery Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by Demographic (in Million USD), 2025-2033
  • Table 4: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by Indication (in Million USD), 2025-2033
  • Table 5: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Competitive Structure
  • Table 8: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Key Players